CLINICAL_TRIALS
trial_result
· 2009-08-12
Clinical Trial Update: Predictive Factors for Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH (Study 142003)(P05696) [Phase 4]
Summary
Phase 4 trial update identifying predictive factors for ovarian stimulation with a fixed daily dose of 200 IU recombinant FSH.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Infertility | Phase 4 | Status: COMPLETED | Results posted: 2009-08-12